| scholarly article | Q13442814 |
| P50 | author | Mari-Lynn Drainoni | Q43537707 |
| Cindy Christiansen | Q55382721 | ||
| Allen L Gifford | Q56696053 | ||
| P2093 | author name string | B D Smith | |
| D Thompson | |||
| D McKee | |||
| S Maher | |||
| E Koppelman | |||
| C M Weinbaum | |||
| A H Litwin | |||
| W N Southern | |||
| P2860 | cites work | Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 |
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
| Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | Q28286743 | ||
| Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
| Diagnosis, management, and treatment of hepatitis C | Q29620656 | ||
| Cost-effectiveness of screening patients for hepatitis C. | Q33827367 | ||
| Evaluation of abnormal liver-enzyme results in asymptomatic patients | Q33899029 | ||
| Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis | Q37174447 | ||
| Guideline-concordant hepatitis C virus testing and notification among patients with and without mental disorders | Q37343042 | ||
| Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection. | Q37386468 | ||
| Prevalence of hepatitis C infection in New York City, 2004 | Q37470465 | ||
| Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships | Q39371007 | ||
| Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases | Q39411430 | ||
| Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project | Q39645918 | ||
| Public health impact of antiviral therapy for hepatitis C in the United States | Q39939298 | ||
| Validation of a hepatitis C screening tool in primary care | Q40036925 | ||
| French consensus conference on hepatitis C: screening and treatment | Q42025728 | ||
| A community experience responding to hepatitis C. | Q42908374 | ||
| Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group | Q42983251 | ||
| Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors | Q42984451 | ||
| Updated definitions of healthy ranges for serum alanine aminotransferase levels | Q44047068 | ||
| Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults. | Q45734380 | ||
| Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea. | Q46004991 | ||
| HIV prevalence estimates--United States, 2006. | Q46880600 | ||
| Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program. | Q50890932 | ||
| Prevalence of hepatitis C among psychiatric patients in the public sector. | Q51951423 | ||
| Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. | Q51969974 | ||
| Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results | Q73149033 | ||
| EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement | Q73327648 | ||
| Hepatitis C and alcohol | Q73327665 | ||
| The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update | Q79302506 | ||
| Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies | Q80521927 | ||
| P433 | issue | 7 | |
| P921 | main subject | hepatitis C | Q154869 |
| P304 | page(s) | 474-481 | |
| P577 | publication date | 2010-05-20 | |
| P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
| P1476 | title | Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting | |
| P478 | volume | 18 |
| Q42261507 | "To share or not to share?" Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants. |
| Q36340733 | A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study |
| Q51797246 | A Public Health Approach to Hepatitis C in an Urban Setting. |
| Q38987518 | A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013): do they differ in Egypt? |
| Q35998417 | Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs? |
| Q47553589 | Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy |
| Q35935659 | Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus |
| Q42198665 | Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels. |
| Q38120201 | Current progress in development of hepatitis C virus vaccines. |
| Q35009578 | Developing a multidisciplinary model of comparative effectiveness research within a clinical and translational science award. |
| Q30406126 | Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis |
| Q59654196 | Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting |
| Q35666697 | Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients. |
| Q40161073 | HCV and HBV testing acceptability and knowledge among urban emergency department patients and pharmacy clients |
| Q59357435 | Hepatitis C Screening in Commercially Insured U.S. Birth-cohort Patients: Factors Associated with Testing and Effect of an EMR-based Screening Alert |
| Q41572035 | Hepatitis C virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: cross-sectional analysis of a multisite retrospective cohort study |
| Q38265395 | Hepatitis C virus infection treatment: An era of game changer direct acting antivirals and novel treatment strategies |
| Q33929521 | Hepatitis C virus screening practices and seropositivity among US veterans born during 1945 - 1965 |
| Q45355364 | Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention |
| Q40082158 | High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic |
| Q59418647 | Impact of race/ethnicity and gender on HCV screening and prevalence among U.S. veterans in Department of Veterans Affairs Care |
| Q51872330 | Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010. |
| Q41256468 | Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study |
| Q64936868 | Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system. |
| Q40701509 | No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening |
| Q43040568 | Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites |
| Q37719745 | Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007-2010 and HCHS/SOL studies |
| Q51852531 | Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008. |
| Q37223719 | Profound jaundice in a patient with acute hepatitis C. |
| Q38074389 | Rapid diagnostic HCV antibody assays |
| Q50991688 | Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment". |
| Q36858838 | Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014. |
| Q40317993 | Retention in buprenorphine treatment is associated with improved HCV care outcomes |
| Q40039560 | Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics |
| Q87798658 | Surgeon general's perspectives |
| Q55424407 | Survey of US Correctional Institutions for Routine HCV Testing. |
| Q38099825 | The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease |
| Q42988978 | The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States |
| Q37455611 | The new paradigm of hepatitis C therapy: integration of oral therapies into best practices |
Search more.